(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2...industrialised nations summit, which begins on Sat...obal health issues high on its list// of priority....h officer, addressing the press stated that the G8...hat would establish the basic guidelines for comba...
...ds Agency (FSA) has said that one in five take-out...ews for over 1.3 million Britons// who thrive on t...oncern since many fast-food restaurants were found...properly before packing the food. Also infestation...
...k, all of two years, found his eyelids stuck toget...his eye, instead of using it to treat a head// inj...ye Infirmary where he was administered treatment. ...some improvement, though a major portion of the ey...
... about the inherent risks involved in the consumpt...e human milk is capable of causing food poisoning ...ces that the human milk carries remnants of drugs ...when consumed. Even unhygienic storage of milk, an...
Other Medicine News:(Date:9/4/2008)... Ala., Sept. 4 /- Southern Research I...tes of Health (NIH) has selected,the organization ...ries,Probe Production Center Network (MLPCN). The ...rt of the Molecular Libraries Program which is,des...knowledge of the human,genome and validate future ...
(Date:9/4/2008)...imizing Patient Identification for Targeted Therap...zed Treatment HUNTINGTON BEACH, Calif., and AMS...ia, a world leader in molecular cancer diagnostics...new diagnostic test that,allows physicians to quan...,the estrogen receptor (ER), progesterone receptor...
(Date:9/3/2008)...College of Rheumatology Research and Education Fou...icant Advances in Detecting, T...RNewswire/ -- For the first time during its,unprec...rthritis, the,American College of Rheumatology Res...formation acquired from research funded by the Wit...
(Date:9/3/2008)... showed that Multaq(R) (dronedarone) decreased the...illation or atrial flutter already ad...EWATER, N.J., Sept. 3 /- Th...the ATHENA study were presented today at,the clini...f Cardiology,congress 2008, in Munich, Germany. Pr...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5NCPA Offers New Immunization CE Program 25168 1NCPA Offers New Immunization CE Program 25168 2Study sees need for standardized evaluation of antibody response to HIV 1 25163 1Study sees need for standardized evaluation of antibody response to HIV 1 25163 2Medical doctors who do research could be a dying breed 4377 1Medical doctors who do research could be a dying breed 4377 2Study helps pinpoint genetic variations in European Americans 4374 1Study helps pinpoint genetic variations in European Americans 4374 2Study helps pinpoint genetic variations in European Americans 4374 3...)--Mar 8, 2007 - Vaxiion Therapeutics,Inc. today ...ith,San Diego State University, have discovered a ...ial to protect against several,disease-causing inf...nce online edition of,the journal, Vaccine, and th...e. , While most vaccines contain live micro-organi...
...COUVER, March 12, 2007 /PRNewswire-FirstCall/ - Ch...s" or the "Company") , a,biotechnology company dev... blood disorders, and vascular disease today annou...completion of the,dose-escalation portion of its P...ny,s anti-cancer drug candidate. No dose,limiting ...
Other Medicine Technology:Vaxiion Researchers Discover Novel Vaccine Delivery System in,Collaboration with San Diego State University 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 2Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 3Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 4Chemokine Therapeutics Announces Preliminary Results of CTCE-9908,Phase Ib/II Clinical Trial in Late Stage Cancer Patients 5Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use.
Used for stone manipulation and removal in the urinary tract. Enhanced wire strength permits the basket to expand the ureter more readily than standard flat-wire designs. The Unidex handle facilitate
...d for stone manipulation and removal in the urinar... to retain its shape following extreme torsion. Th...ture by allowing the basket to open at the base of...ign reduces the likelihood of mucosal damage and p...
Used to establish and maintain nephrostomy drainage following pyeloplasty. Supplied sterile in peel-open packages. Intended for one-time use. CAUTION: Periodic evaluation is advised; stent must not r
Medicine Products: